GENERAL INDEX. 
Serum antistreptococcic, stability 
of, 492 
standardization of, value of, 
492 
therapeutic results of, 493 
protective, test of, 110 
test, 417 
Silver, nitrate, 157 
Skin, disinfection of, 192 
Smallpox, micro-organisms of, 
648 
Smegma bacillus, 313 
Sodium compounds, 157 
Specific immunity, nature of, 124 
Spirilla, characters of, 39 
Spirillum of Asiatic cholera. See 
Cholera, 568 
Finkler and Prior’s, 589 
biology, 589 
morphology, 589 
pathogenesis, 591 
Metschnikovi, 593 
biological characters of, 594 
Obermeieri, 596 
in relapsing fever, 596 
Sporagenous granules, 42 
Spores, staining of, 203 
Spore types, 48 
Sputum, collection of material, 
301 
from consumptive patients, dis- 
infection of, 174 
general rules in microscopical 
examination of, 308 
methods of examination for 
tubercle bacilli in, 302 
washing of, 306 
Staining solutions, ordinary, 200 
Staphylococcus epiderniis albus, 
471 
pyogenes albus, 471 
aureus, 461 
biology, 461 
growéh- in common media, 
462 
immunization, 467 
morphology, 461 
occurrence in man, 468 
pathogenesis of, 464 
production of toxic sub- 
stances by, 466 
691 
Staphylococcus pyogenes citreus, 
472 
Sterilization, fractional, 149 
incomplete, 152 
Sternberg bulb, 25] 
Streptococci, dettction of, in pus, 
etc., 496 
of, in blood, 496 
Streptococcus erysipelatis, 476 
pyogenes, 476 
biological characters of, 478 
growth on media, 478 
immunity, 487 
morphology of, 477 
occurrence of, in man, 483 
pathogenesis, 481 
toxins of, in sarcoma, 485 
production of toxic 
stances by, 487 
susceptibility to infection by, 
sub- 
use of anti-streptococcic serum, 
489 
Streptothrix, 615, 619 
actinomyces, 616 
in pseudotuberculosis, 619 
Sulphur dioxide gas, 158 
in house disinfection, 189 
Sulphuretted hydrogen, produc- 
tion of, 74 
Sunlight, effect of, 168 
an bacteria eliminated by, 
11 
Syphilis bacillus, 311 
biological and pathogenic 
properties of, 312 
morphology of, 311 
EMPERATURE, effect of, on 
bacteria, 146 
Tetanus antitgxin, 395 
dosage, 400 
persistence in the blood, 398 
production of, for therapeu- 
tic purposes, 397 
results in treatment in teta- 
nus, 399 
technique of testing anti- 
toxin serum, 307 
bacillus, 385 
